- Rating
- 2
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This paper presents TIGER for predicting single-cell spatial gene expression from histology. It constructs cell representations from pathology foundation model tokens and combines a cell-wise focal predictor with a spatial-context predictor through cell- and gene-specific gating. Evaluation includes internal cross-validation, external cohorts, and downstream applications.
Critical strengths
- The paper addresses an important problem and evaluates the method across multiple cancer types, including independent external cohorts.
- Sparsity-aware metrics complement conventional correlation measures and provide a more informative assessment of single-cell predictions.
- Patient-level statistical comparisons and computational efficiency measurements strengthen the experimental evaluation.
Critical weaknesses
-
Limited methodological novelty. TIGER mainly combines established designs: token-based cell representations, local/global context modeling, and adaptive gating. The paper does not sufficiently establish what methodological advance this combination offers beyond existing approaches.
-
Limited contribution of the additional modules. The focal-only predictor—a simple MLP on extracted cell features—already outperforms all reported baselines in Table 2. The full model provides only small further gains, increasing PCC from 0.286 to 0.295 and AUC-PR from 0.320 to 0.324. These results suggest that much of the advantage comes from the cell representations, while the contribution of the context and gating modules remains limited.
-
Comparisons with recent single-cell ST prediction methods, such as GHIST+[1] and CELLO[2], should be included.
[1] Zhang, A., Yu, L., Bian, B., et al. Generalisable tissue-wide molecular reconstruction from histology.
[2] Gao, Z., Gu, C., Xiang, J., Luo, X., and Heng, P.-A. Towards Scalable Context-Aware Single-Cell Spatial Transcriptomics Prediction from Histology Images
Questions for authors
see weaknesses
4 comments
Response to Reviewer ZoPT (2/3)
W2. Contribution of the context and gating modules
Cell representation. We agree that the focal expert alone achieves strong performance. However, we clarify that the focal expert is not simply an MLP applied to conventional cell features; its performance stems from our cell representation, which pools PFM tokens inside the cell boundary and is not a conventional cell feature. The ablation above (W1) evaluates this contribution separately: token-based pooling clearly outperforms CLS-based crops and simpler token variants.
Gene-level analysis. Although the overall gains over the focal expert look modest for metrics averaged across genes and patients (PCC 0.295 vs. 0.286, AUC-PR 0.324 vs. 0.320; Table 5), they become clear gene by gene. The full TIGER outperforms the focal expert on 69.2% of genes (626/904), with more pronounced benefits for immune genes than for non-immune genes (65.7%, 471/717). In lung, the complete architecture improves the PCC of immune genes by 6.6% (0.198 → 0.211), twice the gain on non-immune genes (3.2%). Spatial context thus contributes information for genes whose expression individual-cell morphology cannot explain. These analyses have been included in Section 5.2 of the revised manuscript: Context matters differently for different genes.
Fully adaptive gate. TIGER integrates context selectively, per-gene and per-cell. Our results show that, once the focal expert has a strong cell representation, context improves performance if it is incorporated adaptively. Simpler integration strategies (averaging, late fusion, gene-level gating and the newly added cell-level gating) do not improve over the focal expert (PCC 0.280–0.287 vs. 0.286). Only the fully adaptive gate does (0.295), so the benefit of context depends jointly on the gene and on the cell's local environment.
| Focal | Average | Late fusion | Gene adaptive | Cell adaptive | Fully adaptive (TIGER) | |
|---|---|---|---|---|---|---|
| PCC ↑ | 0.286 (±0.027) | 0.280 (±0.026) | 0.280 (±0.025) | 0.287 (±0.026) | 0.283 (±0.025) | 0.295 (±0.024) |
| AUC-PR ↑ | 0.320 (±0.026) | 0.319 (±0.025) | 0.320 (±0.024) | 0.319 (±0.025) | 0.320 (±0.024) | 0.324 (±0.025) |
Table 5, macro-average over the three internal cohorts (all gating variants trained on the same splits).
External datasets and cell phenotyping. We also compared the full TIGER with its individual experts beyond internal cross-validation. On the external breast and lung cohorts, TIGER significantly outperforms the focal expert on PCC ( q < 0.001), Recall and AUC-PR (q < 0.01), with no difference on PCC+, and significantly outperforms the context expert on all metrics except PCC+. In cell phenotyping on the colorectal cohort (16 slides), TIGER reaches the highest macro precision (0.452), significantly above the context (0.421) and focal (0.432) experts (p < 0.01). Its accuracy matches the focal expert (0.581 vs. 0.579) and exceeds the context expert (0.558, p < 0.05).
| GHIST (strongest baseline) | Context expert | Focal expert | TIGER | |
|---|---|---|---|---|
| Macro precision ↑ | 0.351*** | 0.421** | 0.432** | 0.452 |
| Accuracy ↑ | 0.510** | 0.558* | 0.579 | 0.581 |
Colorectal cohort, 16 slides. Stars: TIGER significantly better.
Together, these results show two complementary contributions: token-based cell representations that give strong prediction even with a simple MLP, and adaptive context that adds gene-dependent gains. The strong focal expert thus demonstrates the cell representation rather than diminishing TIGER's contribution.
Response to Reviewer ZoPT (3/3)
W3. Comparison with GHIST+ and CELLO
New baselines. We thank the reviewer for pointing us to these recent methods. GHIST+ was preprinted in June and CELLO was released after our submission. We have now added both as baselines on the three internal cohorts. Results are reported here and will be included in the final manuscript version. For a controlled comparison, both were re-implemented in our framework from their released code. They use the same inputs as TIGER: UNIv2 token embeddings and CellViT nuclei; and were evaluated under the same protocol as all other baselines (splits, validation-fold checkpoint selection, early stopping, metrics). For GHIST+ we excluded the cross-panel module (not applicable to our setting) and the TMA-based molecular anchoring (it requires measured expression of the test tissue, which would be data leakage).
| Model | PCC ↑ | PCC50 ↑ | PCC+ ↑ | bMAE ↓ | bRMSE ↓ | Recall ↑ | AUC-PR ↑ |
|---|---|---|---|---|---|---|---|
| GHIST+ | 0.224 (0.018) | 0.462 (0.024) | 0.185 (0.015) | 0.429 (0.008) | 0.568 (0.009) | 0.309 (0.008) | 0.272 (0.010) |
| CELLO | 0.266 (0.017) | 0.496 (0.027) | 0.237 (0.014) | 0.430 (0.009) | 0.498 (0.009) | 0.321 (0.009) | 0.309 (0.010) |
| TIGER | 0.283 (0.027) | 0.526 (0.036) | 0.237 (0.020) | 0.430 (0.013) | 0.497 (0.014) | 0.329 (0.022) | 0.319 (0.025) |
Macro-average over lung, breast and colorectal. Best in bold.
TIGER is best on PCC, PCC50, bRMSE, Recall and AUC-PR, and ties CELLO on PCC+. GHIST+ attains a marginally lower bMAE, but with the highest bRMSE and the lowest correlation scores. CELLO is the strongest baseline. Like TIGER it uses cell-located token embeddings, which supports token-level PFM representations at single-cell resolution. TIGER's gate, which weighs local morphology and context for each cell and gene, gives higher patient-level PCC than CELLO in every cohort (lung 0.221 vs. 0.206, breast 0.384 vs. 0.374, colorectal 0.245 vs. 0.219).
Gene-level comparison with CELLO. The gap is clearer gene by gene: TIGER has higher PCC on 83.0% of genes (significantly on 30.5%), and CELLO is not significantly better on any gene.
| Cohort | Genes | TIGER better | Significantly better (q < 0.05) | Significantly worse (q < 0.05) |
|---|---|---|---|---|
| Lung (16 patients) | 302 | 251 (83.1%) | 101 (33.4%) | 0 |
| Breast (11 patients) | 280 | 217 (77.5%) | 13 (4.6%) | 0 |
| Colorectal (16 patients) | 322 | 282 (87.6%) | 162 (50.3%) | 0 |
| Total | 904 | 750 (83.0%) | 276 (30.5%) | 0 |
"Better" = higher mean per-patient PCC. Significance: paired one-sided t-test across patients, BH-corrected across genes.
Where the gap comes from. A closer look at the colorectal cohort shows that most of the gap arises from genes for which CELLO predicts zero expression in all cells: ~42 genes per slide (81 on at least one slide), mainly rare markers of scattered cell populations such as sparse immune cells (CD40LG, CTSG, S100A12). TIGER is significantly better on 84% of these genes (68/81) vs. 39% of the remaining genes. Our context-only branch shows the same collapse, whereas the cell-anchored focal branch retains the signal. The fully adaptive gate lets TIGER rely on the focal branch for these genes, instead of averaging their signal away with the neighbourhood context.
We thank the reviewer again for the constructive feedback. We have added both requested baselines and the analyses that separate the contributions of the cell representation, the context branch and the gate. We hope that these additions address the concerns, and we would be grateful if the reviewer would consider revisiting the score.
Dear Reviewer,
Thank you once again for your thoughtful review and valuable feedback. We have provided a detailed rebuttal addressing the concerns raised in your review.
With the discussion period drawing to a close, we would greatly appreciate it if you could review our responses at your convenience. We would be happy to address any remaining questions or provide further clarification.
Thank you once again for your thoughtful consideration.
Response to Reviewer ZoPT (1/3)
W1. Methodological novelty
TIGER architecture. While TIGER builds on established components in computational pathology, its contribution lies far beyond simply combining them; the cohesive framework was designed to carefully address the gene sparsity, an innate property of single-cell ST, while incorporating tissue spatial context. Our extensive ablation experiments show that each and every design choice matters and that simpler alternatives fail. Such delicate balancing is what we achieve, a design desideratum overlooked in other previous single-cell virtual ST frameworks [1,2,3].
Cell representation. Most prior single-cell methods represent each cell by the CLS token of a pathology foundation model (PFM) of a re-encoded or centered image crop or use a CNN encoder. In contrast, TIGER pools the PFM tokens that overlap each cell, weighted by area, levering local morphology encoded by PFM typically overlooked in previous works. In the new cell-embedding ablation (Table 4b; below), this outperforms CLS-based alternatives (PCC 0.220 vs. 0.117 for nucleus crops and 0.171 for cell-centred crops), as well as simpler token-based cell representations. Among existing methods, only the concurrent CELLO also uses token-based cell embeddings. TIGER outperforms it on 83% of genes (significantly on 30.5%; see Q3), which shows that token-based embeddings alone do not explain TIGER's performance.
Adding context naively removes sparse signal and a fully adaptive gate solves this issue. Context aggregation helps spatially coherent genes but smooths out sparse, cell-intrinsic expression. For example, the context-only branch collapses on rare markers of scattered cell populations, such as sparse immune cells, whereas the focal branch retains their signal. TIGER's gate is learned for each cell and gene, so it can rely more on the focal branch for sparse genes and on context for spatially coherent ones. In the fusion ablation (Table 5), it outperforms four other aggregation mechanisms. At the gene level, TIGER improves PCC over the focal branch on 69% of genes and over the context branch on 85%, and the gate value relates to gene sparsity (Fig. A8), indicating that the gate combines the complementary strengths of both branches rather than defaulting to either one.
Biologically grounded architectural design. TIGER's biologically motivated architecture consistently outperforms technically elaborate methods, including PHEONIX and sCellST, across diverse cohorts and evaluation metrics. These results highlight that carefully designed architectures grounded in biological principles can be more effective than architectural complexity alone. TIGER architecture ranks first on every metric across the three internal cohorts, with significant gains over every baseline (Table 2, Table A3). Without retraining, it improves PCC over the strongest baseline by up to 73% (breast) and 109% (lung) on the external cohorts, and it transfers remarkably better to Atera, the new 10x Genomics whole-transcriptome platform (PCC improvement of 64%; Appendix A.7.4, Table A9).
Task-specific evaluation metrics. Beyond our methodological contributions, we introduce several novel, sparsity-aware metrics that comprehensively assess prediction error, correlation, and expression detection in single-cell virtual ST, addressing the limitations of PCC, which remains the predominant but insufficient evaluation standard in the field.
[1] Zhang, Daiwei, et al. "Inferring super-resolution tissue architecture by integrating spatial transcriptomics with histology" Nature biotechnology (2024)
[2] Chadoutaud, Loïc, et al. "sCellST predicts single-cell gene expression from H& E images" Nature Communications (2026)
[3] Fu, Xiaohang, et al. "Spatial gene expression at single-cell resolution from histology using deep learning with GHIST" Nature methods (2025)